Product Information

LABETALOL HCL 200 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.1442 per EA under NDC 00904745261. Its NADAC has been published 70 times since Feb 26, 2025.

LABETALOL HCL 200 MG TABLET

Labetalol Hydrochloride
$0.1442per EA

Strength

200 mg/1

NDC

00904745261

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

LABETALOL HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA209603

On Market Since

10/8/2024

Pharmacological Classes

Adrenergic beta-Antagonists
beta-Adrenergic Blocker

Price Statistics

The NADAC for LABETALOL HCL 200 MG TABLET has been published 70 times since Feb 26, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.1442 per EA
All-time high$0.1493 (Jul 16, 2025)
All-time low$0.1422 (Mar 18, 2026)
52-week high$0.1493
52-week low$0.1422
Median price$0.1453
Average price$0.1456
Largest weekly change-3.4% (Nov 19, 2025)
Weeks tracked70
Tracking sinceFeb 26, 2025

Price History

1W

0.0%

1M

-0.7%

3M

+1.4%

6M

+0.1%

1Y

-3.4%

3Y

N/A

5Y

N/A

All

-1.5%

Generic Alternatives

The matcher finds 11 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LABETALOL HCL 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LABETALOL HCL 200 MG TABLET, manufactured by Major Pharmaceuticals, is $0.1442 per EA (NDC 00904745261), effective Jun 24, 2026.

How has the price of LABETALOL HCL 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for LABETALOL HCL 200 MG TABLET has held within roughly two percent of its current level. It has been tracked across 70 weekly CMS publications since Feb 26, 2025.

What are the highest and lowest recorded NADAC prices for LABETALOL HCL 200 MG TABLET?

Since Feb 26, 2025, the NADAC for LABETALOL HCL 200 MG TABLET has ranged from a low of $0.1422 (Mar 18, 2026) to a high of $0.1493 (Jul 16, 2025), with a median of $0.1453 per EA.

Are there cheaper alternatives to LABETALOL HCL 200 MG TABLET?

Yes. 11 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LABETALOL HCL 200 MG TABLET, is $0.1435 per EA — about 1% below LABETALOL HCL 200 MG TABLET.

Who manufactures LABETALOL HCL 200 MG TABLET?

LABETALOL HCL 200 MG TABLET (NDC 00904745261) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.